Astrazeneca India updates: news & description

Presence

AstraZeneca Pharma India develops, manufactures, and sells prescription medicines. Its main products support cancer, heart, kidney, respiratory, and rare disease care for hospitals, doctors, and patients in India.

Astrazeneca India products and services overview:

Oncology medicines
Cardiovascular care
Kidney disease care
Respiratory medicines
Rare disease therapies
Biopharmaceuticals

Revenue: ~$170 million

Employees: 1,400

Headquarters: Bengaluru, India

Astrazeneca India is owned by AstraZeneca.

AstraZeneca is one of the...

AstraZeneca is a company listed under the stock ticker AZN (GB).

AstraZeneca has a direct presence in 31 countries.

AstraZeneca has 48 subsidiaries including Alexion Pharma Europe, Alexion Pharma France and Alexion Pharma Ireland.

They are in:

Acquisition, funding and merger involving AstraZeneca.

AstraZeneca has acquired SixPeaks Bio (posted on November 19 2025).
AstraZeneca has acquired Fusion Pharma (posted on June 6 2024).

Executives

View the org chart displaying its 23 main executives

Most searched biographies at Astrazeneca India

Popular executive movements at Astrazeneca India

Ayush Kumar Agarwal, Director, Biopharmaceutical Business Unit, will leave the company on Jun. 12, 2026 (posted on June 3 2026).
Ajaykumar Sharma, Director, Corporate & State Affairs, has left the company (posted on March 26 2026).
Tanya Sanish has joined the company as Company Secretary and Compliance Officer (posted on February 13 2026).

Popular executive movements at AstraZeneca

Cindy Hoots, Chief Digital Officer and Chief Information Officer, has left the company (posted on May 27 2026).
Maria Shipulieva Fernandez has joined the company as President, Southern Cone (posted on May 19 2026).
Alan Harrison, Global Head,Talent and Talent Scouting, has left the company (posted on May 19 2026).

Click here to view some more movements at AstraZeneca

Create your alert
to follow the executive moves at Astrazeneca India.